Dalmia Bharat to acquire JAL cement capacity in central India from Adani Group for ₹2,850 crore

Dalmia Bharat to acquire JAL cement capacity in central India from Adani Group for ₹2,850 crore

Dalmia Cement (Bharat) Limited (“DCBL”), a wholly owned subsidiary of Dalmia Bharat Limited, has announced the execution of a Business Transfer Agreement to acquire cement assets previously held by Jaiprakash Associates Limited (“JAL”), which was recently acquired by the Adani Group under the Insolvency & Bankruptcy Code (IBC) framework. The Agreement Details The agreement, executed…

Read More
Nykaa Q4 profit surges nearly 4x as revenue logs highest growth in 12 quarters

Nykaa Q4 profit surges nearly 4x as revenue logs highest growth in 12 quarters

Nykaa reported a sharp rise in fourth-quarter earnings, with consolidated net profit jumping to ₹78.4 crore in Q4FY26 from ₹20.3 crore in the corresponding quarter last year, supported by strong revenue growth and margin expansion. Revenue from operations grew 28.4% year-on-year to ₹2,648.2 crore from ₹2,061.8 crore, marking the company’s highest growth in the last…

Read More
CBI files chargesheet against 15 accused in ₹1,000 crore Haryana bank fraud case

CBI files chargesheet against 15 accused in ₹1,000 crore Haryana bank fraud case

The Central Bureau of Investigation (CBI) has filed its first chargesheet in the multi-bank misappropriation case involving the alleged diversion of nearly ₹1,000 crore from accounts of various Haryana government departments. The agency has chargesheeted 15 accused, including six bank officials from IDFC FIRST Bank and AU Small Finance Bank, three public servants from Haryana…

Read More
Juniper Hotels Q4 revenue rises 8%; profit dips on exceptional items

Juniper Hotels Q4 revenue rises 8%; profit dips on exceptional items

Juniper Hotelsreported a decline in consolidated net profit for the fourth quarter of FY26, with profit falling to ₹50.4 crore from ₹55 crore in the corresponding quarter last year, impacted by exceptional items related to Bengaluru fire insurance, property tax assessment and gratuity liability adjustments. Revenue for the quarter rose 8.4% year-on-year to ₹301 crore…

Read More
Aurobindo Pharma Q4 net profit, revenue rise on Europe growth; US sales decline

Aurobindo Pharma Q4 net profit, revenue rise on Europe growth; US sales decline

Drug maker Aurobindo Pharma Ltd on Thursday (May 21) reported a 2% year-on-year increase in consolidated net profit to ₹921 crore for the March quarter, compared with ₹903 crore in the corresponding quarter last year. Revenue rose 5.6% year-on-year to ₹8,853.3 crore from ₹8,382.1 crore, supported by growth across businesses. EBITDA up 0.5% to ₹₹1,801…

Read More